Impacts of Aronia on Inflammation and the Gut Microbiome
Determining the Gut Microbiota-dependent Impacts of Anthocyanin-rich Aronia Berries on Obese Individuals of Distinct Inflammatory Phenotypes
1 other identifier
interventional
40
1 country
1
Brief Summary
The overall goal of this project is to determine the inflammation lowering impact of anthocyanin-rich Aronia berries. Inflammation is an underlying mechanism driving the development of several diseases. While an elevation in immune signals in the systemic circulation is commonly attributed to adipose tissue, inflammation is not present in all obese individuals. Adipose tissue must become inflamed, and the inflammation trigger may come from other sources. Microorganisms (microbiome), host tissues, and immune cells residing in the gastrointestinal tract (GIT) are a key source of pro-inflammatory signals that may cause the host organism to become inflamed. Anthocyanins are bioactive compounds with established anti-inflammatory and microbiome altering properties. We hypothesize that the GIT microbiome is a key determinant of host inflammation than can be manipulated by anthocyanins-rich berries to lower inflammation. We assembled a cohort of individuals, characterized their GIT microbiome and performed anthropometric measurements, basal measures of metabolism and metabolic health, and triglyceridemic, metabolomic, and inflammation responses to a high-fat meal challenge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedFirst Submitted
Initial submission to the registry
October 14, 2019
CompletedFirst Posted
Study publicly available on registry
October 16, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 27, 2021
CompletedJanuary 16, 2024
January 1, 2024
5 months
October 14, 2019
January 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (18)
Inflammation state
Serum levels of a eight cytokine panel: interleukin (IL)-1B, IL-6, IL-10, IL-17, IL-23, tumor necrosis factor-alpha (TNF-a), granulocyte macrophage-colony stimulating factor (GM-CSF), interferon gamma (IFNy)
1 day
Gut microbiome
Taxonomic composition of the gut microbiome measured from 16s rRNA sequencing of stool samples
1 day
Gut Metabolome
Stool sample metabolome
1 day
Postprandial TG Response to a High-fat Meal Challenge
TG concentrations before, 1, 2, 4, and 6 hours following consumption of a meal containing 50 g of fat (toast with butter)
1 day
Postprandial Inflammation Response to a High-fat Meal Challenge
Cytokine panel (IL-1B, IL-6, IL-10, IL-17, IL-23, TNF-a, GM-CSF, and IFNy) before, 1, 2, 4, and 6 hours following consumption of a meal containing 50 g of fat (toast with butter)
1 day
Postprandial Metabolomic Response to a High-fat Meal Challenge
Serum metabolome before, 1, 2, 4, and 6 hours following consumption of a meal containing 50 g of fat (toast with butter)
1 day
Glycemic control
Hemoglobin A1c (% glycosylation)
1 day
Fasting glucose
Fasting serum glucose (mM)
1 day
Fasting insulin
Fasting serum insulin (pmol/l)
1 day
Lipid panel
Fasting serum TG, LDL, HDL, and total cholesterol
1 day
Fasting metabolites
Serum metabolome measured after an overnight fast
1 day
Self-reported physical activity
Self report of the number of days each week in which aerobic, strength, and stretching type exercises are performed
1 day
Blood pressure
Resting systolic and diastolic blood pressure (mmHg)
1 day
Body composition
Body composition (% fat, %lean)
1 day
Height
Height (m)
1 day
Weight
Weight (kg)
1 day
Waist circumference
Waist circumference (cm)
1 day
Visceral adipose tissue
Volume of visceral adipose tissue (l)
1 day
Study Arms (2)
Aronia juice (ARO)
EXPERIMENTALA juice blend of three different cultivars was used: Viking, MacKenzie and Autumn Magic. Raw juice was heat pasteurized before provided to participants. Participants consumed 100 mL of juice per day for duration of intervention period (28-30 days)
Placebo juice (PLA)
SHAM COMPARATORThe placebo juice was flavor, color, and carbohydrate-matched to experimental Aronia juice. PLA consisted of 28.8 g black cherry Koolaid mix (no sugar added), 128.5 g sorbitol, 74.5 g glucose, 77.9 g fructose, 4 oz lemon juice, 16 drops of blue food coloring, and enough water to create 1 L of solution. Participants consumed 100 mL of juice per day for duration of intervention period (28-30 days)
Interventions
A juice blend of three different cultivars was used: Viking, MacKenzie and Autumn Magic. Raw juice was heat pasteurized before provided to participants. Participants consumed 100 mL of juice per day.
The placebo was flavor, color, and carbohydrate-matched to aronia juice. The placebo consisted of 28.8 g black cherry Koolaid mix (no sugar added), 128.5 g sorbitol, 74.5 g glucose, 77.9 g fructose, 4 oz lemon juice, 16 drops of blue food coloring, and enough water to create 1 L of solution. Participants consumed 100 mL of juice per day.
Eligibility Criteria
You may qualify if:
- BMI 28-35 kg/m\^2
You may not qualify if:
- Antibiotics up to 90 days prior to enrollment
- Anti-inflammatory medications
- Allergy or intolerance to wheat or dairy
- Hormone-based birth control (with exception of intrauterine device)
- Pregnant
- Heart disease
- Other health conditions or concerns that may interfere with study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montana State University
Bozeman, Montana, 59717, United States
Related Publications (1)
Wilson SM, Maes AP, Yeoman CJ, Walk ST, Miles MP. Determinants of the postprandial triglyceride response to a high-fat meal in healthy overweight and obese adults. Lipids Health Dis. 2021 Sep 20;20(1):107. doi: 10.1186/s12944-021-01543-4.
PMID: 34544430DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary P Miles, PhD
Montana State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Placebo (PLA) was flavor, color, and carbohydrate matched to intervention treatment of Aronia juice. PLA consisted of 28.8 g black cherry Koolaid mix (no sugar added), 128.5 g sorbitol, 74.5 g glucose, 77.9 g fructose, 4 oz lemon juice, 16 drops of blue food coloring, and enough water to create 1 L of solution. Participants consumed 100 mL/ day.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2019
First Posted
October 16, 2019
Study Start
April 27, 2019
Primary Completion
September 30, 2019
Study Completion
December 27, 2021
Last Updated
January 16, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share